1. Arroyo J, Álvarez AM, Nombela C, Sánchez-Pérez M (1995) The role of HLA-DPβ residue 69 in the definition of antibody-binding epitopes. Human Immunology 43: 219–226
2. Begovich AB, McClure GR, Suraj VC, Helmuth RC, Fildes N, Bugawan TL, Erlich HA, Klitz W (1992) Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol 148: 249–258
3. Berretta F, Butler RH, Diaz G, Sanarico N, Arroyo J, Fraziano M, Aichinger G, Wucherpfennig KW, Colizzi V, Saltini C, Amicosante M (2003) Detailed analysis of the effects of Glu/Lys human leukocyte antigen-DP polymorphism on peptide-binding specificity. Tissue Antigens 62: 459–471
4. Buckley JD, Buckley CM, Ruccione K, Sather HN, Waskerwitz MJ, Woods WG, Robison LL, For The Children's Cancer Group (1994) Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. Leukemia 8: 856–864
5. Bugawan TL, Horn GT, Long CM, Mickelson E, Hansen JA, Ferrara GB, Angelini G, Erlich HA (1988) Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-α and DP-β loci. J Immunol 141: 4024–4030